BIOMAT Database Logo BIOMAT Database Logo

[Felden (piroxicam) in arthroses. A post-marketing study]. 1983

H K Brath, and H P Madsbu, and F Brosstad

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010894 Piroxicam A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. CP-16171,Feldene,CP 16171,CP16171
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

H K Brath, and H P Madsbu, and F Brosstad
[Piroxicam (Felden)].
September 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H K Brath, and H P Madsbu, and F Brosstad
[Piroxicam (Felden) in primary dysmenorrhea].
October 1984, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H K Brath, and H P Madsbu, and F Brosstad
[Adverse effects following piroxicam (Felden)].
February 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H K Brath, and H P Madsbu, and F Brosstad
[Analgesic effectiveness of Felden (piroxicam) in chronic polyarthritis. A placebo controlled study].
January 1980, Wiener medizinische Wochenschrift (1946),
H K Brath, and H P Madsbu, and F Brosstad
[Piroxicam (Felden) in acute soft tissue injuries. A multicenter, double-blind, randomized study].
June 1985, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H K Brath, and H P Madsbu, and F Brosstad
[Comparative study of piroxicam and indomethacin retard in arthroses].
November 1981, Fortschritte der Medizin,
H K Brath, and H P Madsbu, and F Brosstad
[Piroxicam in degenerative joint diseases (arthroses) in orthopedics].
January 1980, Wiener medizinische Wochenschrift (1946),
H K Brath, and H P Madsbu, and F Brosstad
[Scientific basis of piroxicam (Felden). Pharmacological properties and mechanism of action].
January 1980, Wiener medizinische Wochenschrift (1946),
H K Brath, and H P Madsbu, and F Brosstad
[Piroxicam (Felden), in the form of 20 mg suppositories, in the treatment of acute and chronic rheumatic diseases].
April 1984, Revue medicale de la Suisse romande,
H K Brath, and H P Madsbu, and F Brosstad
Post-marketing Study of Linagliptin: A Pilot Study.
January 2019, Frontiers in pharmacology,
Copied contents to your clipboard!